Abstract:Previously, we found that the incidence of kidney injury in patients with chronic hypoxia was related to the partial pressure of arterial oxygen. However, at oxygen concentrations that contribute to kidney injury, the changes in the relationship between microRNAs (miRNAs) and the hypoxia-inducible factor-1α (HIF-1α)-vascular endothelial growth factor (VEGF) axis and the key miRNAs involved in this process have not been elucidated. Therefore, we elucidated the relationship between VEGF and kidney injury at different oxygen concentrations and the mechanisms mediated by miRNAs. Sprague-Dawley rats were exposed to normobaric hypoxia and categorized into six groups based on the concentration of the oxygen inhaled and injection of the angiogenesis inhibitor bevacizumab, a humanized anti-VEGF monoclonal antibody. Renal tissue samples were processed to determine pathological and morphological changes and HIF-1α, VEGF, and miRNA expression. We performed a clustering analysis of high-risk pathways and key hub genes. The results were validated using two Gene Expression Omnibus datasets (GSE94717 and GSE30718). As inhaled oxygen concentration decreased, destructive changes in the kidney tissues became more severe. Although the kidney possesses a self-protective mechanism under an intermediate degree of hypoxia (10% O2), bevacizumab injections disrupted this mechanism, and VEGF expression was associated with the ability of the kidney to repair itself. rno-miR-124-3p was identified as a crucial miRNA; a key gene target, Mapk14, was identified during this process. VEGF plays an important role in kidney protection from injury under different hypoxia levels. Specific miRNAs and their target genes may serve as biomarkers that provide new insights into kidney injury treatment.NEW & NOTEWORTHY Renal tolerance to hypoxic environments is limited, and the degree of hypoxia does not show a linear relationship with angiogenesis. VEGF plays an important role in the kidney's self-protective mechanism under different levels of hypoxia. miR-124-3p may be particularly important in kidney repair, and it may modulate VEGF expression through the miR-124-3p/Mapk14 signaling pathway. These microRNAs may serve as biomarkers that provide new insights into kidney injury treatment.

Short-Term Activation of Hypoxia-Inducible Factor Slows Kidney Disease Progression in Rat Model of 5/6 ;subtotal Nephrectomy by Up-regulating MiR-29c Expression

Transient Hypoxia-Inducible Factor Activation in Rat Renal Ablation and Reduced Fibrosis with L-Mimosine

The Balance of Beneficial and Deleterious Effects of Hypoxia-Inducible Factor Activation by Prolyl Hydroxylase Inhibitor in Rat Remnant Kidney Depends on the Timing of Administration

miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Expression and Location of Hypoxia Inducible Factor-1Α and -2Α in the Remnant Kidney of 5/6 Nephrectomy Rats

[Expression of HIF-1alpha in 5/6-Nephrectomized Rat Models of Chronic Kidney Fibrosis].

MicroRNA-489 Induction by Hypoxia-Inducible Factor-1 Protects Against Ischemic Kidney Injury.

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

Abstract P125: RNA Sequencing of Left-ventricular Tissue Highlights Novel Pathways Impacted by the Loss of Mir-146B-5p in a Rat Model of Chronic Kidney Disease

MicroRNA-216a-5p Alleviates Acute Kidney Injury of Mice via Suppressing FAS Ligand Expression

MicroRNA-21 Regulates Peroxisome Proliferator–activated Receptor Alpha, a Molecular Mechanism of Cardiac Pathology in Cardiorenal Syndrome Type 4

Abstract 61: Mirna-21 Targets Left Ventricular Peroxisome Proliferator-activated Receptor Alpha in a Rat Model of Type 4 Cardiorenal Syndrome

Dynamic Changes of the Expression of Hypoxia Inducible Factor-1A and the Target Genes Mir-210, Vascular Endothelial Growth Factor in the Kidney after Ischemic-Reperfusion Injury

Propofol Attenuates Renal Ischemia/reperfusion Injury by Regulating the MALAT1/miR-126-5p Axis

Human Tissue Kallirein Gene Delivery in Inhibiting Renal Fibrosis in Remnant Rats of 5/6 Nephrectomized Rats Via Inhibition of Apoptosis and Inflammation

Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys

Analysis of microRNA expression in rat kidneys after VEGF inhibitor treatment under different degrees of hypoxia

miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway.

The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/β-Catenin Signaling

Inhibition Of Mirna-135a-5p Ameliorates Tgf-Beta 1-Induced Human Renal Fibrosis By Targeting Sirt1 In Diabetic Nephropathy